Which Patients Benefit from Radiation Therapy in Diffuse Large B-Cell Lymphoma in 2023? Recent Evidence and Future Developments
The role of RT in DLBCL is changing. Recent randomized studies have challenged the role of RT in the primary treatment of DLBCL but they included selected patient populations, making application of results in routine clinical practice difficult.
Category
  • Hematologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
ASTRO/ILROG Joint Session - When Every Centigray Counts: Expert Panelists on Approaching and Optimizing the Most Challenging Lymphoma Plans
Ongoing advances in technology have allowed for the shrinkage of target volumes and lowering of doses in the treatment of lymphomas with radiation.
Category
  • Hematologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
At the Cutting Edge: The Increasing Role of Salvage Radiotherapy in Relapsed/Refractory Lymphomas
Recently, there have been exciting advances in the treatment of relapsed/refractory (R/R) lymphomas. Historically, the standard-of-care included salvage chemotherapy followed by autologous stem cell transplantation (ASCT). Today, many other salvage options are available.
Category
  • General RO
  • Head and Neck
  • Hematologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Is Consolidation Radiotherapy Still Needed for Lymphoma in 2024? Reappraisal in Light of Recent Trials Results
Radiotherapy plays an important role as a consolidation treatment after systemic therapy, either to shorten the course of systemic therapy and reduce hematological, cardiac and fertility toxicity or to reduce the risk of relapse e.g., for bulky masses.
Category
  • Hematologic
  • Patient Safety
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Red Journal Oncology Scans - 2024
The field of cancer is a rapidly evolving field with new treatment approaches moving to clinic on a daily basis. Radiation Oncology is no different. It is extremely difficult for a practicing clinician to stay abreast of new developments in cancer care.
Category
  • Breast
  • Gastrointestinal
  • Gynecologic
  • Head and Neck
  • Hematologic
  • Professional Development
  • Sarcoma
  • SBRT
  • Thoracic
Format
  • Journal Activities
Credits
  • 7.00 AMA PRA Category 1 Credit™
  • 7.00 Certificate of Attendance
Cost $299.00
Gray Zone - A Blast from the Past: Definitive Management of Favorable Early Stage Hodgkin Lymphoma Ineligible for Systemic Therapy
The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.
Category
  • Hematologic
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $0.00
2024 ASTRO Annual Refresher Course onDemand
This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most major sub-disciplines of radiation oncology, including sarcomas, pediatrics and lymphomas, and the role of radiotherapy in the multidiscipl
Category
  • Breast
  • Central Nervous System
  • Gastrointestinal
  • Genitourinary
  • Gynecologic
  • Head and Neck
  • Hematologic
  • Pediatric
  • Physics
  • Radiobiology
  • Sarcoma
  • Thoracic
Format
  • Meetings onDemand
Credits
  • 22.75 AMA PRA Category 1 Credit™
  • 22.75 Certificate of Attendance
Cost $1,049.00
How High Can We Go - How Low Should We Aim? Normal Tissue Dose/Volume Constraints in Lymphoma Radiation Therapy Planning
Normal tissue dose-volume constraints are commonly used for lymphoma radiation therapy (RT) planning.
Category
  • Hematologic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00